Early Development of the Mouse Morphome

Joseph A Hampel1, Jacob Rinkinen, Jonathan R Peterson

  • 1*Unit for Laboratory Animal Medicine†Department of Surgery, University of Michigan Medical School, Ann Arbor, MI.

Abstract

Insights

This study developed a microCT imaging protocol for longitudinal animal studies. The refined method provides reliable, objective data for morphomic analysis, advancing research in frailty and bone health.

Area of Science:

  • Biomedical Imaging
  • Osteoporosis Research
  • Animal Models

Background:

  • Analytical morphomics uses quantitative data from CT scans to assess patient frailty.
  • Current morphomics studies are retrospective, limiting controlled prospective research.
  • Developing animal models is crucial for prospective, well-controlled morphomics studies.

Purpose of the Study:

  • To establish an in vivo microCT protocol for longitudinal, whole-body imaging in research animals.
  • To enable morphomic analyses of bone structure and density.
  • To create a platform for testing hypotheses derived from human clinical morphomics.

Main Methods:

  • Phantom studies were conducted on two microCT systems (Inveon and CT120) to evaluate tissue radiodensity and system performance.
  • A phantom-immobilization device was designed and tested using phantoms and an ovariectomized (OVX) mouse model.
  • Data analysis involved assessing scan consistency, the impact of field-of-view objects, and the utility of using the middle 80% of slices.

Main Results:

  • The Inveon system demonstrated greater z-axis consistency than the CT120; slice-by-slice calibration reduced variability.
  • Using the middle 80% of slices significantly decreased data variability on both systems.
  • Bone mineral density calibration with a phantom improved estimates, and the OVX mouse model was validated by body weight and uterine mass comparisons.

Conclusions:

  • A refined microCT protocol was developed for acquiring reliable, objective data in research animals.
  • This protocol establishes a foundation for animal morphomics research.
  • The platform will facilitate testing hypotheses generated from human clinical morphomics studies.